65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award
Active Awarded Last action
- Contract number
- 36F79723D0219
- Awardee
-
Genentech Usa, Inc. UEI SA85BMHCTXK5
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 4
Award facts
- Opportunity
-
- 65IB Solicitation number
- Last date to order 62% complete
- IDV ceiling
- $4,927,972,430.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs Veterans Integrated Service Network 12 issued a Federal Supply Schedule contract to Genentech USA, Inc. on September 15, 2023, under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, with a contract ceiling of $4.927 billion and performance through September 14, 2028. This multi-agency GSA schedule vehicle enables ordering agencies to place delivery orders directly against Genentech's approved price list rather than conducting separate competitions.
Genentech is approved under FSS-61-IB for pharmaceutical and biologic products, including antivirals, oncology therapeutics, and critical-care injectables. The contract carries no set-aside designation. Work is performed at Genentech's South San Francisco, California facility.
Recent ordering activity under this Federal Supply Schedule contract reflects strategic national-stockpile and pandemic-response procurement. The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response issued a $74.97 million delivery order on September 26, 2025, for Xofluza (baloxavir marboxil) 40mg and 80mg tablets, with completion by September 29, 2027. ASPR also placed a $45.1 million delivery order on January 30, 2025, for Oseltamivir Phosphate (Tamiflu) 30mg and 75mg capsules. Additional delivery orders under the FSS-61-IB include a $21.99 million Xofluza order from ASPR awarded September 30, 2024, and a $397 million Tamiflu order from ASPR awarded November 17, 2023. A blanket purchase agreement for Evrysdi with a $1.725 million ceiling was awarded September 22, 2023, and exercised through September 21, 2027. The schedule supports Genentech's role as a primary supplier of critical pharmaceuticals and antivirals to federal health and defense agencies.
Task orders
IDV awards
| IDV | Agency | Ceiling | Awarded |
|---|---|---|---|
| 36E79723A0022 | National Acquisition Center (VA) | $1,725,140 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 |
Show 40 more
Latest 50 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract 36F79723D0219?
36F79723D0219 was awarded to Genentech Usa, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on September 15, 2023.
How much is contract 36F79723D0219 worth?
36F79723D0219's own ceiling is $4,927,972,430.
How many orders have been placed under contract 36F79723D0219?
4 orders have been placed under 36F79723D0219, the latest on September 26, 2025.
Who can order from contract 36F79723D0219?
36F79723D0219 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79723D0219 part of a contract vehicle?
Yes. 36F79723D0219 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79723D0219 competed?
The extent of competition for 36F79723D0219 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV